- Open
- 2.48
- High
- 2.49
- Low
- 2.44
- Close
- 2.48
- Change
- +0.00 (0.00%)
- Volume
- 214,583
| 3 Aug 2026 | 07:00:04 | Total Voting Rights |
| 29 Jul 2026 | 07:00:06 | Yarrow Bioscience merges with VYNE Therapeutics |
| 15 Jul 2026 | 07:00:06 | Monthly Valuation Update and Factsheet |
| 10 Jul 2026 | 07:00:02 | Transaction in Own Shares |
| 1 Jul 2026 | 07:01:00 | Total Voting Rights |
| 24 Apr 2026 | Annual Report and Audited Consolidated Financial Statements | |
| 17 Apr 2025 | Annual Report and Audited Consolidated Financial Statements | |
| 25 Apr 2024 | Annual Report and Accounts |
RTW Biotech Opportunities Ltd invests in the biotechnology and healthcare sectors, focusing on companies that develop pharmacological and medical therapeutic assets. Its geographic focus is global, with an emphasis on identifying growth potential in life sciences. The trust aims for long-term capital appreciation through a diversified portfolio across various therapeutic categories and product types.
Baroness Blackwood of North Oxford has interests in this issuer
| 3 Aug 2026 | 07:00:04 | Total Voting Rights |
| 29 Jul 2026 | 07:00:06 | Yarrow Bioscience merges with VYNE Therapeutics |
| 15 Jul 2026 | 07:00:06 | Monthly Valuation Update and Factsheet |
| 10 Jul 2026 | 07:00:02 | Transaction in Own Shares |
| 1 Jul 2026 | 07:01:00 | Total Voting Rights |
| 24 Apr 2026 | Annual Report and Audited Consolidated Financial Statements | |
| 17 Apr 2025 | Annual Report and Audited Consolidated Financial Statements | |
| 25 Apr 2024 | Annual Report and Accounts |
RTW Biotech Opportunities Ltd invests in the biotechnology and healthcare sectors, focusing on companies that develop pharmacological and medical therapeutic assets. Its geographic focus is global, with an emphasis on identifying growth potential in life sciences. The trust aims for long-term capital appreciation through a diversified portfolio across various therapeutic categories and product types.
Baroness Blackwood of North Oxford has interests in this issuer
| Issuer | Mkt cap | 1Y |
|---|---|---|
| $99.14bn | +0.1% | |
| $2.25bn | +0.0% | |
RTWRTW Biotech Opportunities Ltd | $858m | +0.9% |
| $324m | +0.1% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| $99.14bn | +0.1% | |
| $2.25bn | +0.0% | |
RTWRTW Biotech Opportunities Ltd | $858m | +0.9% |
| $324m | +0.1% |
